Operating Margin in % of ImmunityBio, Inc. from 2014 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
ImmunityBio, Inc. quarterly/annual Operating Margin history and change rate from 2014 to Q3 2025.
  • ImmunityBio, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -316 %, a 93.6% increase year-over-year.
  • ImmunityBio, Inc. annual Operating Margin for 2024 was -2.33K %, a 96% increase from 2023.
  • ImmunityBio, Inc. annual Operating Margin for 2023 was -58.2K %, a 60.2% increase from 2022.
  • ImmunityBio, Inc. annual Operating Margin for 2022 was -146K %, a 314% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

ImmunityBio, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -316 +4.6K +93.6% 01 Jul 2025 30 Sep 2025
Q2 2025 -504 +27K +98.2% 01 Apr 2025 30 Jun 2025
Q1 2025 -1K +114K +99.1% 01 Jan 2025 31 Mar 2025
Q4 2024 -2.33K +55.9K +96% 01 Oct 2024 31 Dec 2024
Q3 2024 -4.91K +60.2K +92.5% 01 Jul 2024 30 Sep 2024
Q2 2024 -27.5K +35.4K +56.2% 01 Apr 2024 30 Jun 2024
Q1 2024 -115K -51.9K -82.9% 01 Jan 2024 31 Mar 2024
Q4 2023 -58.2K +88.1K +60.2% 01 Oct 2023 31 Dec 2023
Q3 2023 -65.1K -3.01K -4.84% 01 Jul 2023 30 Sep 2023
Q2 2023 -62.9K +3.17K +4.8% 01 Apr 2023 30 Jun 2023
Q1 2023 -62.6K -20.6K -49% 01 Jan 2023 31 Mar 2023
Q4 2022 -146K -111K -314% 01 Oct 2022 31 Dec 2022
Q3 2022 -62.1K -12.2K -24.4% 01 Jul 2022 30 Sep 2022
Q2 2022 -66.1K -24.7K -59.7% 01 Apr 2022 30 Jun 2022
Q1 2022 -42K -10.7K -34.2% 01 Jan 2022 31 Mar 2022
Q4 2021 -35.4K -11.5K -48.3% 01 Oct 2021 31 Dec 2021
Q3 2021 -49.9K -27.6K -124% 01 Jul 2021 30 Sep 2021
Q2 2021 -41.4K -22.1K -115% 01 Apr 2021 30 Jun 2021
Q1 2021 -31.3K +11.1K +26.2% 01 Jan 2021 31 Mar 2021
Q4 2020 -23.9K +134K +84.9% 01 Oct 2020 31 Dec 2020
Q3 2020 -22.3K +147K +86.8% 01 Jul 2020 30 Sep 2020
Q2 2020 -19.3K +110K +85.1% 01 Apr 2020 30 Jun 2020
Q1 2020 -42.5K +146K +77.4% 01 Jan 2020 31 Mar 2020
Q4 2019 -158K +51.6K +24.7% 01 Oct 2019 31 Dec 2019
Q3 2019 -169K +34.7K +17% 01 Jul 2019 30 Sep 2019
Q2 2019 -129K +238K +64.8% 01 Apr 2019 30 Jun 2019
Q1 2019 -188K +73.2K +28% 01 Jan 2019 31 Mar 2019
Q4 2018 -209K +10.9K +4.96% 01 Oct 2018 31 Dec 2018
Q3 2018 -204K +6.39K +3.04% 01 Jul 2018 30 Sep 2018
Q2 2018 -367K -157K -74.5% 01 Apr 2018 30 Jun 2018
Q1 2018 -261K -19.9K -8.22% 01 Jan 2018 31 Mar 2018
Q4 2017 -220K +62.7K +22.2% 01 Oct 2017 31 Dec 2017
Q3 2017 -210K +76.9K +26.8% 01 Jul 2017 30 Sep 2017
Q2 2017 -210K +122K +36.8% 01 Apr 2017 30 Jun 2017
Q1 2017 -242K -46.1K -23.6% 01 Jan 2017 31 Mar 2017
Q4 2016 -283K -182K -180% 01 Oct 2016 31 Dec 2016
Q3 2016 -287K -221K -333% 01 Jul 2016 30 Sep 2016
Q2 2016 -332K -295K -785% 01 Apr 2016 30 Jun 2016
Q1 2016 -195K -188K -2419% 01 Jan 2016 31 Mar 2016
Q4 2015 -101K -100K -11538% 01 Oct 2015 31 Dec 2015
Q3 2015 -66.3K 01 Jul 2015 30 Sep 2015
Q2 2015 -37.6K 01 Apr 2015 30 Jun 2015
Q1 2015 -7.76K 01 Jan 2015 31 Mar 2015
Q4 2014 -870 01 Oct 2014 31 Dec 2014

ImmunityBio, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -2.33K +55.9K +96% 01 Jan 2024 31 Dec 2024
2023 -58.2K +88.1K +60.2% 01 Jan 2023 31 Dec 2023
2022 -146K -111K -314% 01 Jan 2022 31 Dec 2022
2021 -35.4K +1.15K +3.14% 01 Jan 2021 31 Dec 2021
2020 -36.5K -29.4K -415% 01 Jan 2020 31 Dec 2020
2019 -7.1K +202K +96.6% 01 Jan 2019 31 Dec 2019
2018 -209K +10.9K +4.96% 01 Jan 2018 31 Dec 2018
2017 -220K +62.7K +22.2% 01 Jan 2017 31 Dec 2017
2016 -283K -182K -180% 01 Jan 2016 31 Dec 2016
2015 -101K -100K -11538% 01 Jan 2015 31 Dec 2015
2014 -870 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.